K131653

Substantially Equivalent

LZI ORAL FLUID AMPHETAMINE ENZYME IMMUNOASSAY, CALIBRATORS, CONTROLS

Applicant: Lin-Zhi International, Inc.
Product code: DKZ
Advisory panel: Clinical Toxicology
Date received: 2013-06-05
Decision date: 2014-02-04
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sunnyvale, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.